gefitinib has been researched along with deoxyglucose in 1 studies
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (deoxyglucose) | Trials (deoxyglucose) | Recent Studies (post-2010) (deoxyglucose) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 11,426 | 171 | 1,375 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kim, AMJ; Kim, B; Lim, SO; Oh, W; Schwarz, JR; Sun, R | 1 |
1 other study(ies) available for gefitinib and deoxyglucose
Article | Year |
---|---|
Saccharide analog, 2-deoxy-d-glucose enhances 4-1BB-mediated antitumor immunity via PD-L1 deglycosylation.
Topics: Animals; Antibodies; Antineoplastic Agents; B7-H1 Antigen; Cell Line; Cell Line, Tumor; Deoxyglucose; Female; Gefitinib; Glucose; HEK293 Cells; Humans; Immunotherapy; Mice; Mice, Inbred BALB C; Triple Negative Breast Neoplasms | 2020 |